A phase I clinical trial of CXR1002 in patients (pts) with advanced cancer

M. Macpherson; D. Bissett; B. Tait; L. M. Samuel; J. MacDonald; A. L. Barnett; C. R. Wolf; C. R. Elcombe; A. Jeynes-Ellis; T. R. J. Evans

doi:10.1016/S1359-6349(10)72098-X

A phase I clinical trial of CXR1002 in patients (pts) with advanced cancer

M. Macpherson
, D. Bissett
, B. Tait
, L. M. Samuel
, J. MacDonald
, A. L. Barnett
, C. R. Wolf
, C. R. Elcombe
, A. Jeynes-Ellis
, T. R. J. Evans

Research output: Contribution to journal › Book/Film/Article review › peer-review

Original language	English
Pages (from-to)	124
Number of pages	1
Journal	EJC Supplements
Volume	8
Issue number	7
DOIs	https://doi.org/10.1016/S1359-6349(10)72098-X
Publication status	Published - 2010

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/S1359-6349(10)72098-XLicence: Elsevier User Licence

Cite this

@article{ba7a49e883144f8083c12d0074745069,

title = "A phase I clinical trial of CXR1002 in patients (pts) with advanced cancer",

author = "M. Macpherson and D. Bissett and B. Tait and Samuel, \{L. M.\} and J. MacDonald and Barnett, \{A. L.\} and Wolf, \{C. R.\} and Elcombe, \{C. R.\} and A. Jeynes-Ellis and Evans, \{T. R. J.\}",

year = "2010",

doi = "10.1016/S1359-6349(10)72098-X",

language = "English",

volume = "8",

pages = "124",

journal = "EJC Supplements",

issn = "1359-6349",

publisher = "Elsevier",

number = "7",

}

TY - JOUR

T1 - A phase I clinical trial of CXR1002 in patients (pts) with advanced cancer

AU - Macpherson, M.

AU - Bissett, D.

AU - Tait, B.

AU - Samuel, L. M.

AU - MacDonald, J.

AU - Barnett, A. L.

AU - Wolf, C. R.

AU - Elcombe, C. R.

AU - Jeynes-Ellis, A.

AU - Evans, T. R. J.

PY - 2010

Y1 - 2010

U2 - 10.1016/S1359-6349(10)72098-X

DO - 10.1016/S1359-6349(10)72098-X

M3 - Book/Film/Article review

SN - 1359-6349

VL - 8

SP - 124

JO - EJC Supplements

JF - EJC Supplements

IS - 7

ER -